Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance and Re-assessment of the actual benefit following the Transparency Committee conclusions in its opinions of 26 November 2008 and reiterated in its opinion of 21 September 2011.
Clinical Benefit
| Insufficient |
The actual benefit of PIASCLEDINE 300 mg capsules is in sufficient to justify reimbursement by National Insurance. |
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
R85ZVx01dXYnF9h6
